RecallDepth
Class I Terminated

Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens (NDC 49502-394-71), packaged in cartons of 5 prefilled pens (NDC 49502-394-75), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 15317, Manufactured for: Mylan Specialty L.P., Morgantown, WV

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
July 5, 2022
Posted
August 3, 2022
Recall Number
D-1292-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
253,200 pens (50,650/5 per packs)
Firm Location
Morgantown, WV, United States

Reason for Recall

Labeling: Missing label: Label missing from some prefilled pens.

Distribution

Product was distributed nationwide within the United States

Lot / Code Info

Lot #: BF21002895, Exp. Date Aug 2023

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class I Drug recalls